Literature DB >> 32252143

Association between assisted reproductive technology and autism spectrum disorders in Iran: a case-control study.

Ensiyeh Jenabi1, Mahdieh Seyedi1, Ronak Hamzehei2, Saeid Bashirian3, Mohammad Rezaei1, Katayoon Razjouyan4, Salman Khazaei5.   

Abstract

BACKGROUND: Autism spectrum disorder (ASD) is a neurodevelopmental disorder defined by impairments in social interaction and verbal and nonverbal communication.
PURPOSE: Determine the association between use of assisted reproduction technology (ART) and the risk of ASD among children.
METHODS: This case-control study included 300 participants (100 cases, 200 controls). The control group included women with a child aged 2-10 years without ASD, while the cases were women with a child aged 2-10 years with ASD. We used a researcher-made questionnaire. Data were analyzed using Stata ver. 14 at the 0.05 significance level.
RESULTS: In the univariate analysis, there was significant association between child sex, delivery mode, history of preterm delivery, history of using ART, and maternal age at child's birth and the risk of ASD. After the adjustment for other variables, this association was significant for male sex (2.66; 95% confidence interval [CI], 1.11-4.31; P=0.001) and history of using ART (4.03; 95% CI, 1.76-9.21; P=0.001). Therefore, after the adjustment for confounder variables, there was no significant association between ART and the risk of ASD among children (4.98; 95% CI, 0.91-27.30; P=0.065).
CONCLUSION: After the adjustment for other variables, risk factors for ASD were male sex and history preterm delivery. Thus, there was no significant association between ART and the risk of ASD among children.

Entities:  

Keywords:  Assisted reproductive technology; Autism spectrum disorder; Case-control study

Year:  2020        PMID: 32252143      PMCID: PMC7462823          DOI: 10.3345/cep.2020.00073

Source DB:  PubMed          Journal:  Clin Exp Pediatr        ISSN: 2713-4148


Graphical abstract. Assisted reproductive technology (ART) is a risk factor for autism spectrum disorders.

Introduction

Autism spectrum disorder (ASD) is a neurodevelopmental disorder defined by impairments in social interaction and verbal and nonverbal communication [1]. The prevalence of ASD has dramatically increased in the last decades. Despite much attempt to treat ASD and care system, it is still a major public health problem worldwide [2]. Recent research has reported that both genetic and environmental risk factors are effective in etiology of ASD [3]. Maternal prepregnancy obesity, preeclampsia, neonatal icterus, and low birth weight (LBW) are risk factors for ASD among children [4,5]. There is evidence that parents of children with ASD are more likely to have infertility compared with parents of children without ASD. Therefore, infertility treatments may be affected for ASD [6]. The use of assisted reproduction technology (ART) such as zygote intrafallopian transfer, gamete intrafallopian transfer, in vitro fertilization (IVF), induced ovulation, and insemination has increased in worldwide [7]. ASD and ART have similar risk factors including advanced maternal and paternal [8]. Also, ART can be leads to preterm labor and LBW, these factors are associated with ASD [9]. Fountain et al. [10] in 2015 found the association between ART and ASD greatly decreased after adjusting for the pregnancy outcomes. Therefore, this shows the importance of controlling for confounding factors. Other study by Schieve et al. [11] in 2017 in the United States (US) showed that ASD was not associated with ART or non-ART infertility treatments. Davidovitch et al. [6] reported that IVF treatment compared with spontaneous conception was not statistically significantly associated with the risk of ASD among children. However, the results of studies are inconsistent. Therefore, the aim of this study was to determinate the association between use of ART and the risk of ASD among children through a case-control study in west of Iran.

Methods

This case-control study was conducted on 300 participants (100 cases and 200 controls) in Hamadan city for 3 months (September to November). The inclusion criteria for the control group were: women who had child without ASD and they had health records at comprehensive health centers in Hamadan city (Capital of Hamadan province). Hamadan city has a population of 651,820 people according to the national census held by the Statistical Center of Iran in 2016. There is in Hamadan city 110 children with ASD aged 2–10 years. The inclusion criteria for the case group were: women who had child with ASD aged 2–10 years and they were recruited from the Hamadan Autism Community who had medical records in the Community. In their medical record, children with ASD were screened by The Modified Checklist for Autism in Toddlers (M-Chat) and were diagnosed by autism diagnostic interviewrevised (ADI-R). ADI-R is currently the most adequate and most widely used diagnostic tool for autism study [12]. These tools include questions about emotional sharing, offering and seeking comfort, social smiling, and responding to other children. The cutoff scores for social interaction, communication and language, and restricted/repetitive behaviors are 10, 8 (if verbal) or 7 (if nonverbal) and 3 [13]. They referred to autism center to receive health service for their child. In this study, all women completed the questionnaire with informed consent. This study took from September 10 to November 10, 2019. The protocol of this study was approved by Hamadan University of Medical Sciences with code 9804112799 and ethical code: IR.UMSHA.REC.1398.288. There were a total of 110 ASD children between the ages of 2–10 years in Hamadan city. Therefore, all children with ASD between 2–10 years of age in Hamadan city were included in this study through census method. Also, in order to increase the study power, 2 healthy children aged 2–10 years were considered as control for each case. The parents of 10 children with ASD were not satisfied for participate in this study. Therefore, we included 100 cases and 200 controls in the present study. We used a researcher-made questionnaire including: the paternal and maternal age, child's age, mother's job, parity, history of preterm labor in children aged 2–10 years, delivery type, mode of conception (medication, intrauterine insemination, IVF, and spontaneous), use of ART and cause of infertility (ovulation, unspecified, uterus, Donated oocyte, spouse, fibroma, and endometritis). Univariable logistic regression was conducted to estimate crude association between mother and child variables and odds of ASD in child. Those with P value ≤0.2 were considered as potential significant determinants of ASD and were included in multivariable logistic regression. Bootstrapping using 1,000 bootstrap samples was used to check internal validity of multivariable model and to address the possibility of optimism. Data were analyzed using the Stata ver. 14 (Stata Corp., College Station, TX, USA) at 0.05 significance level.

Results

A total of 100 cases and 200 controls were compared in the study. A full comparison of variables related mother and child as well as the results of univariable logistic regression analyses associated with ASD is shown in Table 1. In univariable analysis, child’s sex (boys vs. girls), type of delivery (cesarean vs. natural delivery), having history of preterm delivery, mothers with history of using ART, maternal age at child’s birth (≥35 years vs. <35 years) were potentially associated with higher odds of ASD (P value≤0.2). In this study, none of the mothers used alcohol or cigarette.
Table 1.

Univariate logistic regression analysis of predictors of ASD

VariableASD
OR (95% CI)P value
No (n=200)Yes (n=100)
Sex
 Girl94 (47.00)22 (22.00)Reference
 Boy106 (53.00)78 (78.00)3.14 (1.82–5.44)<0.001
Type of delivery
 Natural111 (55.50)38 (38.00)Reference
 Cesarean89 (44.50)62 (62.00)2.03 (1.25–3.32)0.005
History of preterm delivery
 No189 (94.50)79 (79.00)Reference
 Yes11 (5.50)21 (21.00)4.57 (2.1–9.92)<0.001
ART
 No198 (99.00)92 (92.00)Reference
 Yes2 (1.00)8 (8.00)8.61 (1.79–41.34)0.007
Maternal age at child birth
 <35 years180 (90.00)82 (82.00)Reference
 ≥35 years20 (10.00)18 (18.00)1.97 (0.99–3.93)0.049
Paternal age at child birth
 <35 years139 (69.50)68 (68.00)Reference
 ≥35 years61 (30.50)32 (32.00)1.07 (0.64–1.80)0.79
Maternal education
 Primary school37 (18.50)16 (16.00)Reference
 Guidance school42 (21.00)15 (15.00)0.83 (0.36–1.89)0.65
 Diploma62 (31.00)33 (33.00)1.23 (0.60–2.54)0.57
 Academic59 (29.50)36 (36.00)1.41 (0.69–2.89)0.35
Paternal education
 Primary school22 (11.00)7 (7.00)Reference
 Guidance school45 (22.50)27 (27.00)1.89 (0.71–5.00)0.21
 Diploma62 (31.00)28 (28.00)1.42 (0.54–3.71)0.48
 Academic71 (35.50)38 (38.00)1.68 (0.66–4.29)0.28

Values are presented as number (%).

ASD, autism spectrum disorder; OR, odds ratio; CI, confidence interval; ART, assisted reproduction technology.

Boldface indicates a statistically significant difference with P<0.05.

In detail, among ASD cases, 78 (78.00%) were boy while corresponding figure among control group was 53%. In other words, the odds of ASD in boys was 3.14 (95% CI, 1.82–5.44; P<0.001). Moreover, in ASD cases 62% of children were born through cesarean section compared with 44.5% in control group (odds ratio [OR], 2.03; 95% CI, 1.25–3.32; P=0.005). The proportion of preterm delivery among cases and controls was 21% and 5.5%, respectively (OR, 4.57; 95% CI, 2.1–9.92; P<0.001). The odds of ASD in child among mothers with using assisted reproduction was 8.61 folds higher (P=0.007). Table 2 shows the results of the multivariate logistic regression. After adjusting for other variables, odds of ASD among boys was 2.66 (95% CI, 1.11–4.31; P=0.001) compared girls. Cesarean delivery was associated with 63% increase in odds of ASD (OR, 1.63; 95% CI, 0.96–2.76; P=0.07). The odds of ASD in children that their mothers had history of preterm delivery and history of using ART were 4.03 (1.76–9.21; P=0.001) and 4.98 (0.91–27.3; P=0.065), respectively. For better understanding results of crude and adjusted logistic regression is depicted in Fig. 1.
Table 2.

Original and bootstrapped multivariate analyses of mother and neonate variables associated with ASD

VariableOriginal model
Bootstrapped model
OR (95% CI)P valueOR (95% CI)P value
Sex
 GirlReferenceReference
 Boy2.66 (1.50–4.72)0.0012.66 (1.41–5.01)0.002
Type of delivery
 NaturalReferenceReference
 Cesarean1.63 (0.96–2.76)0.071.63 (0.94–2.83)0.08
History of preterm delivery
 NoReferenceReference
 Yes4.03 (1.76–9.21)0.0014.03 (1.72–9.42)0.001
ART
 NoReferenceReference
 Yes4.98 (0.91–27.30)0.0654.98 (1.06–23.33)0.042
Maternal age at birth (yr)
 <35ReferenceReference
 ≥351.72 (0.82–3.64)0.151.72 (0.75–3.93)0.195

ASD, autism spectrum disorder; OR, odds ratio; CI, confidence interval; ART, assisted reproduction technology.

Boldface indicates a statistically significant difference with P<0.05.

Fig. 1.

Graphical presentation of crude and adjusted logistic regression analysis of predictors of autism spectrum disorder.

Using 1,000 bootstrap samples, it found that there were high consistency and stability between the resulting ORs (95% CIs) from the original dataset and those from the bootstrapped model.

Discussion

Our findings showed that after adjusting for other variables, risk factors for ASD were boy sex and history preterm delivery for children with ASD. Therefore, after adjusting for confounder variables, there was not significant association between ART and the risk of ASD among children. Lung et al. [8] in 2017 in Taiwan reported that ART was a potential risk factor associated with ASD in large national birth cohort study. Fountain et al. [10] in 2015 in US reported that the incidence of diagnosed ASD was twice as high for ART compared with non-ART births. The association was reduced after adjustment for demographic factors and adverse pregnancy outcomes substantially, although this association was statistically significant for mothers aged 20–34 years [10]. While, other study by Schieve et al. [11] in 2017 in US showed that ASD was not associated with ART or non-ART infertility treatments. Davidovitch et al. [6] reported that IVF treatment compared with spontaneous conception was not statistically significantly associated with the risk of ASD among children. Hvidtjørn et al. [14], in 2011 in Danish population-based study reported that children conceived using ART had an increased risk of being diagnosed with ASD; however, this association was not seen after controlling of confounder variables such as maternal age, education, parity, smoking, birth weight, and place of births. These results are consistent with the findings of our study. However, there are many potential mechanisms that ART could be associated with ASD such as the biological factors related to the underlying fertility or quality of the germ cells, effects of the fertility hormone therapies used during ART, other effects of the ART methods, and the prenatal and perinatal complications related to ART treatment [15]. Also, fetal steroid hormones during early critical periods of brain development are thought to exert an epigenetic fetal programming mechanism for autism. Progesterone affects myelination through the peripheral nervous system and the central nervous system via through mechanisms that involve both the progesterone receptor and the gamma-aminobutyric acid gamma-aminobutyric acid (GABA) receptor [16]. Therefore, there was specific pathophysiology of the relationship between ASD and ART. In a meta-analysis in 2017 by Wang et al. [17] was found an increased prevalence of ASD in children with preterm delivery (relative risk, 1.31; 95% CI, 1.16–1.48). In the present study, history of preterm delivery for children with ASD was a risk factor. An association between advanced maternal age and ASD has been found in previous studies [9,18]. In our study, there was significant association in crude form, but it disappeared after adjusting for other variables. There were some limitations in our study. First, in observational studies, it is possible that we did not include unmeasured demographic and parental characteristics in our study. Second, we included the income status in the questionnaire but the majority of participants did not answer to this question and this variable was omitted in the analysis. Lastly, family history in children with ASD and epilepsy was not questioned. However, these limitations can be led to bias in the results. In conclusion, our findings showed that after adjusting for other variables, risk factors for ASD were boy sex and history preterm delivery for children with ASD. Therefore, after adjusting for confounder variables, there was not significant association between ART and the risk of ASD among children.
  17 in total

Review 1.  Autism: towards an integration of clinical, genetic, neuropsychological, and neurobiological perspectives.

Authors:  A Bailey; W Phillips; M Rutter
Journal:  J Child Psychol Psychiatry       Date:  1996-01       Impact factor: 8.982

2.  Assisted reproductive technology in Europe, 2003. Results generated from European registers by ESHRE.

Authors:  A Nyboe Andersen; V Goossens; L Gianaroli; R Felberbaum; J de Mouzon; K G Nygren
Journal:  Hum Reprod       Date:  2007-04-30       Impact factor: 6.918

3.  Parental age and the risk of autism spectrum disorders: findings from a Swedish population-based cohort.

Authors:  Selma Idring; Cecilia Magnusson; Michael Lundberg; Mats Ek; Dheeraj Rai; Anna C Svensson; Christina Dalman; Håkan Karlsson; Brian K Lee
Journal:  Int J Epidemiol       Date:  2014-01-09       Impact factor: 7.196

4.  Risk of autism spectrum disorders in children born after assisted conception: a population-based follow-up study.

Authors:  D Hvidtjørn; J Grove; D Schendel; L A Schieve; C Sværke; E Ernst; P Thorsen
Journal:  J Epidemiol Community Health       Date:  2010-06-27       Impact factor: 3.710

5.  Association between assisted reproductive technology conception and autism in California, 1997-2007.

Authors:  Christine Fountain; Yujia Zhang; Dmitry M Kissin; Laura A Schieve; Denise J Jamieson; Catherine Rice; Peter Bearman
Journal:  Am J Public Health       Date:  2015-03-19       Impact factor: 9.308

6.  Brief report: validity of Finnish registry-based diagnoses of autism with the ADI-R.

Authors:  K M Lampi; A Sourander; M Gissler; S Niemelä; K Rehnström; E Pulkkinen; L Peltonen; L Von Wendt
Journal:  Acta Paediatr       Date:  2010-09       Impact factor: 2.299

7.  Maternal and Paternal Infertility Disorders and Treatments and Autism Spectrum Disorder: Findings from the Study to Explore Early Development.

Authors:  Laura A Schieve; Carolyn Drews-Botsch; Shericka Harris; Craig Newschaffer; Julie Daniels; Carolyn DiGuiseppi; Lisa A Croen; Gayle C Windham
Journal:  J Autism Dev Disord       Date:  2017-12

Review 8.  The fetal brain: role of progesterone and allopregnanolone.

Authors:  Nicola Pluchino; Marinella Russo; Andrea R Genazzani
Journal:  Horm Mol Biol Clin Investig       Date:  2016-07-01

9.  Twin-singleton influence on infant development: a national birth cohort study.

Authors:  F-W Lung; B-C Shu; T-L Chiang; S-J Lin
Journal:  Child Care Health Dev       Date:  2009-05       Impact factor: 2.508

Review 10.  The epidemiology and global burden of autism spectrum disorders.

Authors:  A J Baxter; T S Brugha; H E Erskine; R W Scheurer; T Vos; J G Scott
Journal:  Psychol Med       Date:  2014-08-11       Impact factor: 7.723

View more
  2 in total

1.  Is fetal nuchal cord associated with autism spectrum disorder? A meta-analysis.

Authors:  Ensiyeh Jenabi; Maryam Ahmadi; Azam Maleki
Journal:  Clin Exp Pediatr       Date:  2021-09-24

Review 2.  The Consequences of Assisted Reproduction Technologies on the Offspring Health Throughout Life: A Placental Contribution.

Authors:  Mariana Schroeder; Gina Badini; Amanda N Sferruzzi-Perri; Christiane Albrecht
Journal:  Front Cell Dev Biol       Date:  2022-05-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.